Opinion

Video

Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)

Key Takeaways

  • Oral JAK inhibitors provide a convenient alternative to injectable biologics, potentially enhancing patient adherence in maintenance therapy.
  • These inhibitors target specific inflammatory pathways, offering a tailored approach to managing autoimmune conditions.
SHOW MORE

Medical experts review the data on the use of oral JAK inhibitors for maintenance and rescue treatments in atopic dermatitis.

Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
© 2025 MJH Life Sciences

All rights reserved.